Long-term pharmacokinetics of the metabolites of everolimus and cyclosporine in renal transplant recipients

Transplantation Proceedings

Volumn 34, Issue 6, 2002, Pages 2233-2234

  Kirchner, Gabriele I ^a   Mueller, L ^a,b   Winkler, M ^b   Loss, M ^b   Roechte, F ^b   Deters, M ^c   Christians, U ^d   Kaever, V ^c   Klempnauer, J ^b   Sewing, K F ^c   Manns, M P ^a  

^a Department of Gastroenterology and Hepatology ^*  (Germany)

^b Clinic of Visceral and Transplant Surgery   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DRUG METABOLITE; EVEROLIMUS;

AREA UNDER THE CURVE; BLOOD ANALYSIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MASS SPECTROMETRY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RECIPIENT;

BIOTRANSFORMATION; CYCLOSPORINE; DRUG THERAPY, COMBINATION; HUMAN; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; METABOLIC CLEARANCE RATE; SIROLIMUS;

EID: 0036755344     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(02)03217-7     Document Type: Article

References (5)

1. Schuler W., Sedrani R., Cottens S., et al. Transplantation. 64:1997;36.
2. Jacobsen W., Serkova N., Hausen B., et al. Transplant Proc. 33:2001;514.
3. Christians U., Sewing K.F. Pharmacol Ther. 57:1993;291.
4. Crowe A., Lemaire M. Pharm Res. 15:1999;1666.
5. Kirchner G.I., Vidal C., Winkler M., et al. Ther Drug Monit. 21:1999;116.